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Objectives The objective of this study was to investigate the associations of mitral annular calcification, aortic annular calci-
fication, and aortic valve sclerosis with covert magnetic resonance imaging (MRI)–defined brain infarcts.
Background Clinically silent brain infarcts defined by MRI are associated with increased risk for cognitive decline, dementia,
and future overt stroke. Left-sided cardiac valvular and annular calcifications are suspected as risk factors for
clinical ischemic stroke.
Methods A total of 2,680 CHS (Cardiovascular Health Study) participants without clinical histories of stroke or transient isch-
emic attack underwent brain MRI in 1992 and 1993, 1 to 2 years before echocardiographic exams (1994 to 1995).
Results The mean age of the participants was 74.5  4.8 years, and 39.3% were men. The presence of any annular or valvu-
lar calcification (mitral annular calcification, aortic annular calcification, or aortic valve sclerosis), mitral annular calci-
fication alone, or aortic annular calcification alone was significantly associated with a higher prevalence of covert
brain infarcts in unadjusted analyses (p  0.01 for all). In models adjusted for age, sex, race, body mass index, physi-
cal activity, creatinine, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, smoking, diabe-
tes, coronary heart disease, and congestive heart failure, the presence of any annular or valve calcification remained
associated with covert brain infarcts (risk ratio: 1.24; 95% confidence interval: 1.05 to 1.47). The degree of annular or
valvular calcification severity showed a direct relation with the presence of covert MRI findings.
Conclusions Left-sided cardiac annular and valvular calcifications are associated with covert MRI-defined brain infarcts. Fur-
ther study is warranted to identify mechanisms and determine whether intervening in the progression of annular
and valvular calcification could reduce the incidence of covert brain infarcts as well as the associated risk for
cognitive impairment and future stroke. (J Am Coll Cardiol 2011;57:2172–80) © 2011 by the American Col-
lege of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.01.034Mitral annular calcification (MAC), aortic annular calcifi-
cation (AAC), and aortic valve (AV) sclerosis (AVSc) are
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May 24, 2011:2172–80 Cardiac Calcification and Silent Brain Infarctsand on the aortic cusps, respectively (1–4). Clinical precur-
sors of atherosclerosis are also risk factors for MAC and
AVSc (5). MAC and AVSc have been documented to be
independent predictors of cardiovascular events (5,6), al-
though their relationship with clinical ischemic stroke
remains less well defined. Not all studies examining the
association between MAC and stroke have reported a
significant relationship (7–12), whereas an association be-
tween AV calcification and overt stroke has been demon-
strated only in the presence of AV stenosis and not with
AVSc (13).
With the increased use of magnetic resonance imaging
(MRI), covert brain infarcts and white matter lesions
(WMLs) are often seen in elderly people free of prior clinical
transient ischemic attacks (TIA) and stroke (14–16). These
covert MRI findings are not benign, because they are
associated with cognitive decline and future overt stroke
(17). Covert brain infarcts and WMLs are thought to have
a vascular origin possibly related to microembolism along
with microvascular ischemia (18). Data are lacking on the
prevalence and relevance of these covert MRI findings in
patients with MAC, AAC, and AVSc and without histories
of TIA and stroke. Whether cardiac annular and valvular
calcification is related to prevalent covert brain infarcts and
WMLs independent of known and putative stroke risk
factors remains untested.
The CHS (Cardiovascular Health Study) is a large,
community-based study of cardiovascular disease in the
elderly that included cranial MRI and echocardiography.
We used data from the CHS to investigate the hypothesis
that the prevalence of covert brain infarcts and WMLs
would be higher in participants with MAC and calcific AV
disease (defined as AVSc and AAC) than those without.
Methods
Study population. Details of the CHS have been pub-
lished elsewhere (19,20). Briefly, a random sample of men
and women age 65 years and older were recruited from
Medicare eligibility lists in 4 U.S. communities (Sacramento
County, California; Washington County, Maryland; For-
syth County, North Carolina; and Pittsburgh, Pennsylva-
nia). In 1989 and 1990, the original study enrolled 5,201
subjects, and in 1992 and 1993, an additional 687 African
Americans were enrolled. Exclusions included the use of a
wheelchair, institutionalization, inability to give informed
consent, plans to move away from the area within 3 years, or
active treatment for malignancy. Each participating center
received institutional review board approval, and all partic-
ipants gave informed consent.
Of the 5,888 elderly participants in the CHS, 3,101
underwent both MRI in 1992 or 1993 and echocardiogra-
phy in 1994 or 1995. We excluded 245 participants with
clinical histories of stroke or TIA before their MRI or
echocardiography. An additional 140 subjects were excluded
in whom necessary variables from the MRI or echocardio- pgraphic studies could not be de-
fined, as were 36 participants who
were missing covariate informa-
tion. Thus, the sample size for our
primary analysis of covert brain
infarcts was 2,680 participants.
When WMLs were analyzed, our
sample included 2,665 partici-
pants, because 15 participants were
further excluded for lack of a WM
grade measurement.
Measurements. The baseline
examination (closest to and be-
fore MRI) included a standard-
ized interview conducted by
trained CHS study personnel as-
sessing demographics, plus a va-
riety of risk factors, including
smoking, alcohol intake, history
of TIA, stroke, congestive heart
failure, and prior coronary heart
disease (CHD). The physical ex-
amination included standardized
measurements of height, weight,
and seated blood pressure mea-
sured using a random-zero sphygmomanometer. Blood
pressure was measured in triplicate 5 minutes apart. All
patients were instructed to fast. Diabetes was defined as a
clinical history of diabetes, fasting glucose level 126
g/dl, or the use of a diabetic medication. Lipid measure-
ents were made at the Laboratory for Clinical Biochem-
stry Research, and low-density lipoprotein was calculated
sing the Friedewald equation.
chocardiography. Two-dimensional echocardiograms
ere recorded on videotape using a Toshiba SSH-160A
ltrasound machine (Toshiba Corporation, Tokyo, Japan)
uring the 1994 and 1995 CHS examinations, as detailed
reviously (21,22). The echocardiograms were evaluated at a
entralized core laboratory (Georgetown University, Wash-
ngton, DC) by observers blinded to participants’ clinical
istories.
Definitions of AVSc, MAC, and AAC were the same as
n previous CHS studies (2,23). AVSc was identified as
ocal or diffuse aortic cusp thickening, stiffness, and/or
ncreased echogenicity (calcification) with normal aortic
usp excursion and a peak trans-AV flow velocity2.0 m/s.
AC was defined by increased echodensity located at the
unction of the atrioventricular groove and posterior mitral
eaflet on the parasternal long-axis, short-axis, or apical
-chamber view. The presence of AAC was similarly
efined as increased echodensity of the aortic root at the
nsertion of the aortic cusps.
RI. Brain MRI was performed during the 1992 and
993 CHS examinations, 1 to 2 years before the echocar-
iographic exams. Brain MRI was performed and inter-
Abbreviations
and Acronyms
AAC  aortic annular
calcification
AV  aortic valve
AVSc  aortic valve
sclerosis
CHD  coronary heart
disease
CRP  C-reactive protein
HDL  high-density
lipoprotein
LV  left ventricular
MAC  mitral annular
calcification
MRI  magnetic resonance
imaging
NT-proBNP  N-terminal
pro-brain natriuretic peptide
TIA  transient ischemic
attack
WM  white matter
WML  white matter lesionreted without any information about the participant, as
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Cardiac Calcification and Silent Brain Infarcts May 24, 2011:2172–80previously described (24). A brain infarct was defined as an
area of low signal intensity of at least 3 mm on T1-weighted
images that was also visible as a hyperintense lesion on
T2-weighted images. MRI-defined brain infarcts were cat-
egorized as absent or present. WMLs were considered
present if visible as hyperintense on proton-density and
T2-weighted images, without prominent hypointensity on
T1-weighted scans. WMLs were assigned a grade from 0
(best) to 9 (worst) and analyzed as a dichotomous variable
with WM grade 4. Covert MRI findings were defined as:
1) high WM grade of 5 or more; 2) the presence of infarcts;
or 3) both. Infarct location was determined as cortical
infarcts (any infarct involving the cortex or the cerebellar
surface) and noncortical infarcts (any infarct involving basal
ganglia, thalamus, internal capsule, or centrum ovale and
sparing the cortical surface). Noncortical infarcts were
almost entirely 20 mm (25).
Secondary exposure variables. Echocardiographic left
atrial dimensions (in centimeters) were defined in the
parasternal long-axis view, as described (26). Measurement
of left ventricular (LV) internal dimensions in diastole was
used to determine LV mass using an established validated
method (26). LV mass was normalized for height2.7 accord-
ng to published guidelines (26). LV hypertrophy was
efined on the basis of established LV mass cutoffs (26).
trial fibrillation was determined on electrocardiography at
he time of examination or by self-report at any visit up
hrough the last visit before the MRI. Measurement of
-terminal pro-brain natriuretic peptide (NT-proBNP)
as performed using a commercially available immunoassay
Elescys proBNP Assay, Roche Diagnostics, Indianapolis,
ndiana) on the Elescys 2010 instrument. High-sensitivity
-reactive protein (CRP) measurement was performed
sing a latex-enhanced reagent (Dade Behring, Deerfield,
llinois). Cystatin C concentration was measured using a
NII nephelometer (N Latex Cystatin-C, Dade Behring).
T-proBNP, CRP, and cystatin C were all log transformed
nd analyzed as continuous variables.
tatistical analysis. We performed a cross-sectional anal-
sis in participants without histories of clinical TIA or
troke. Echocardiographic variables of annular and valvular
alcification were our exposure variables to be related to the
resence of MRI findings. Because the prevalence of brain
nfarcts was close to 27% in our population, unadjusted and
djusted risk ratios and 95% confidence intervals were
alculated by relative risk regression (27) using Poisson
egression with robust standard errors. MAC, AAC, and
VSc were analyzed as separate and combined independent
ariables. Analyses tested whether: 1) MAC was related to
rain infarct; 2) MAC was related to high WM grade; and
) MAC was related to any MRI finding. This analysis was
epeated for AAC and AVSc, as well as for combined
easures of annular and valvular calcification. Specifically,
he variable “any annular or valvular calcification” included
he presence of MAC, AAC, or AVSc, whereas the variable
all annular or valvular calcification” included the presence bf MAC, AAC, and AVSc together; “any AV calcification”
ncluded AAC and AVSc. Our primary exposure of interest,
pecified a priori, was the presence of the combined mea-
ures of any annular or valvular calcification. The primary
utcome of interest was the presence of covert brain infarcts.
ll other exposure and outcome measures were secondary.
otential confounders associated with annular or valvular
alcification and established stroke risk factors were in-
luded in adjusted models: model 1 (age, sex, and race
djusted) and model 2 (adjusted for age, sex, race, body mass
ndex, physical activity, creatinine, average systolic blood
ressure, total cholesterol, high-density lipoprotein [HDL]
holesterol, smoking, diabetes, and the presence of CHD or
ongestive heart failure at the closest clinic visit before
RI). On the basis of their known associations with
erebrovascular events (left atrial enlargement, atrial fibril-
ation, and LV hypertrophy) or their potential role as
ediators or confounders (NT-proBNP, CRP, and cystatin
), independent predictor variables were analyzed in a priori
xploratory models: model 3 (model 1 plus LV hypertrophy
nd left atrial enlargement) and model 4 (model 1 plus atrial
brillation, CRP, NT-proBNP, and cystatin C). We used
hi-square and regression analysis to examine associations in
trata defined by infarct location: cortical infarct versus
oncortical infarct. Subjects with multiple infarcts were
ncluded in the cortical infarct group if at least 1 infarct was
ortical and in the noncortical group if all infarcts were
oncortical. In regression analyses, those infarcts not of the
ype being examined in the particular stratum were ex-
luded. Stata version 10.1 (StataCorp LP, College Station,
exas) was used for all analyses.
esults
he mean age of the participants in these analyses was
4.5  4.8 years, and 39.3% were men. MAC was found in
0.1%, AAC in 44.3%, and AVSc in 53.3%. The prevalence
f any annular or valvular calcification was 77.0%, whereas
he prevalence for all calcification was 16.0%. Age, creati-
ine level, male sex, white race, history of CHD, NT-
roBNP, and cystatin C levels were all associated with
nnular or valvular calcification (MAC, AAC, or AVSc) in
ivariate comparisons (Table 1). Neither total cholesterol
or HDL cholesterol individually showed a significant
ssociation with any annular or valvular calcification (p 
.08), but the ratio of total cholesterol to HDL cholesterol
id (p  0.03).
ffects on covert brain infarcts. On MRI, 712 partici-
ants (26.6%) had 1 or more covert infarcts, and 161 (6.0%)
ad WM grades 4. The presence of covert brain infarcts
as significantly associated with detection of any annular or
alvular calcification (p  0.001) in bivariate comparisons
Fig. 1). Relative risk regression analysis showed that any
nnular or valvular calcification, MAC, AAC, and any AV
alcification were associated with the presence of covert
rain infarcts in unadjusted models (Table 2). In minimally
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May 24, 2011:2172–80 Cardiac Calcification and Silent Brain Infarctsadjusted models, the presence of MAC, any AV calcifi-
cation, and any annular or valvular calcification were
associated with covert brain infarcts. In models adjusted
for age, sex, race, body mass index, physical activity,
systolic blood pressure, smoking, diabetes, total choles-
terol, HDL cholesterol, creatinine, CHD, and congestive
heart failure, only the presence of any annular or valve
calcification was associated with covert brain infarcts.
Additional a priori exploratory models (models 3 and 4)
adjusting for factors such as LV hypertrophy, left atrial
size, NT-proBNP, CRP, atrial fibrillation, and cystatin C
did not meaningfully change the results (Table 2). When
all annular or valvular calcification was included as the
exposure variable, only unadjusted and minimally ad-
justed models were statistically significant (data not
shown).
Effects on high WM grade. With high WM grade as the
outcome, the presence of any annular or valvular calcifica-
tion, the presence of any AV calcification, and the presence
of AAC were significant determinants associated in unad-
justed models. Only the presence of any annular or valvular
calcification was associated with high WM grade in mini-
mally adjusted and fully adjusted models. The association of
any AV calcification with WM grade was only marginally
significant (Table 3).
Effects on covert brain infarcts and high WM grade.
Descriptive Statistics for the Total Study Cohort and According toTable 1 Descriptive Statistics for the Total Study Cohort and A
Risk Factor
Entire Cohort
(n  2,680)
Any Annular o
(n
Age (yrs) 74.53 4.81 74
BMI (kg/m2) 26.68 4.37 26
Men 1,053 (39.3%) 8
White race 2,275 (84.9%) 1,7
Physical activity (kcal) 1,620.59 1,837.96 1,621
Serum creatinine (mg/dl) 1.03 0.26 1
Systolic BP (mm Hg) 134.22 20.13 134
TC/HDL cholesterol ratio 4.09 1.22 4
TC (mg/dl) 209.31 37.34 210
HDL cholesterol (mg/dl) 54.40 14.73 54
Smoking status
Never smoker 1,224 (45.7%) 9
Former smoker 1,219 (45.5%) 9
Current smoker 237 (8.8%) 1
Diabetes prevalence 317 (11.8%) 2
Presence of CHD 466 (17.4%) 3
Presence of CHF 92 (3.4%)
CRP (mg/dl) 4.68 7.71 4
Natural log of NT-proBNP 229.08 427.25 245
Natural log of cystatin C 1.07 0.26 1
Left atrial size (cm) 4.00 0.93 4
Atrial fibrillation 202 (7.5%) 1
LV hypertrophy 474 (24.4%)
Data are mean  SD and n (%). *Any annular or valve calcification combines the presence of mit
BMI  body mass index; BP  blood pressure; CHD  congenital heart disease; CHF  congest
atriuretic peptide; TC  total cholesterol.When high WM grade and brain infarcts were consid- aered as a combined outcome (Table 4), the results were
consistent with our above models. The presence of any
annular or valvular calcification, any AV calcification,
MAC, and AAC showed significant associations with
combined outcomes in our unadjusted and minimally
adjusted models. In our fully adjusted model and explor-
atory models, only the presence of any annular or valvular
calcification, the presence of any AV calcification, and
the presence of AAC were related to the combined
outcome. AVSc alone was not associated with any brain
MRI finding in any of our models. The degree of valvular
calcification showed a direct relation with the presence of
covert brain MRI lesions. In fully adjusted models,
moderate to severe annular or valvular calcification in the
mitral and aortic position showed a 21% and 19% higher
risk for covert brain infarcts and a 51% and 38% higher
risk for covert brain infarcts and/or high WM grade than
no valvular lesions, respectively, although the difference
was statistically significant only for the relation of AV
lesions with covert brain infarcts (Figs. 2 and 3).
nfarct location analysis. Of the 712 participants with
overt infarcts, 65 (9%) had any cortical infarcts and 647
91%) had noncortical infarcts. The prevalence of cortical
nfarcts versus noncortical infarcts in those with versus
ithout any annular or valvular calcification was not
ignificantly different (p  0.51). Relative risk regression
lar or Valvular Calcification Statusding to Annular or Valvular Calcification Status
e Calcification*
63)
No Annular or Valve Calcification
(n  617) p Value
4.87 73.67 4.52 0.0001
4.31 26.86 4.56 0.22
.8%) 211 (34.2%) 0.003
.8%) 506 (82.0%) 0.02
1,850.79 1,618.67 1,795.90 0.98
0.27 1.01 0.22 0.003
19.82 134.28 21.15 0.93
1.21 3.99 1.24 0.027
37.55 207.00 36.56 0.081
14.61 55.32 15.07 0.076
.7%) 301 (48.8%)
.7%) 256 (41.5%)
6%) 60 (9.7%) 0.07
.0%) 70 (11.4%) 0.85
.4%) 86 (13.9%) 0.01
7%) 15 (2.4%) 0.12
.02 4.68 6.57 0.99
66.02 171.80 241.27 0.0006
.27 1.05 0.21 0.003
.01 3.94 0.58 0.084
4%) 29 (4.7%) 0.002
.3%) 91 (18.8%) 0.001
ular calcification, aortic annular calcification, or aortic valve sclerosis.
rt failure; HDL  high-density lipoprotein; LV  left ventricular; NT-proBNP  N-terminal pro-brainAnnuccor
r Valv
 2,0
.79
.62
42 (40
69 (85
.16
.04
.20
.12
.00
.12
23 (44
63 (46
77 (8.
47 (12
80 (18
77 (3.
.68 8
.57 4
.08 0
.01 1
73 (8.
18 (26
ral annnalysis of any annular or valvular calcification using
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Cardiac Calcification and Silent Brain Infarcts May 24, 2011:2172–80model 2 showed that risk ratios were only slightly
stronger for any cortical infarct than for noncortical
infarcts, but as expected given the small number of
cortical infarcts, the association for this stratum was not
significant (Table 5).
Figure 1 Proportion of Participants With Covert Brain Infarcts
According to Annular or Valve Lesion Status
Data showing a significantly greater proportion of covert brain infarcts in partici-
pants with any annular or valvular calcification compared with those without
any annular or valvular calcification. MRI  magnetic resonance imaging.
Risk Ratios (95% Confidence Intervals) Describing the AssociationMAC, AAC, and AVSc and Covert Brain InfarctsTable 2 Risk Ratios (95% Confide ce Intervals) Describing theMAC, AAC, and AVSc and Covert Brain Infarcts
Variable Unadjusted p Value Model 1 p Value
Any annular or
valve calcification
1.33 (1.12–1.57) 0.001 1.27 (1.08–1.50) 0.005
MAC 1.21 (1.06–1.37) 0.003 1.15 (1.01–1.30) 0.035
AAC 1.17 (1.03–1.33) 0.014 1.11 (0.98–1.26) 0.108
AVSc 1.08 (0.95–1.23) 0.224 1.07 (0.94–1.21) 0.323
Any AV calcification* 1.21 (1.05–1.41) 0.009 1.16 (1.00–1.35) 0.044
*Any AV calcification: combination of AAC or AVSc. Model 1: adjusted for age, sex, and race (whit
blood pressure, total cholesterol, high-density lipoprotein cholesterol, smoking status (never, forme
visit before brain magnetic resonance imaging. Model 3: adjusted for age, race, sex, left ventricular
peptide, C-reactive protein, cystatin C, and atrial fibrillation.
AAC  aortic annular calcification; AV  aortic valve; AVSc  aortic valve sclerosis; MAC  mitral annDiscussion
In a community-based sample of older adults, we found that
the presence of any left-sided cardiac annular or valvular
calcification was significantly associated with a 33% greater
risk for covert brain infarcts on MRI in participants without
histories of TIA or stroke. This observed association per-
sisted after full adjustment for potential confounders. Sim-
ilar associations were observed with the presence of high
WM grade and when covert brain infarcts and high WM
grade were analyzed as a combined MRI-defined outcome.
Additionally, we used explanatory models with comprehen-
sive adjustment for clinical confounders and echocardio-
graphic and inflammatory covariates. Our findings remained
independent of NT-proBNP, CRP, and cystatin C, sug-
gesting that the primary association represents more than
simply shared risk factors.
Prior studies have reported inconsistent findings with
respect to the association between left-sided cardiac
annular or valvular calcifications and the risk for clinical
stroke. MAC and AAC are characterized by calcium and
lipid deposition in the annular fibrosa, whereas AVSc
results from similar accumulation involving the AV
leaflets (1,28). Although numerous case reports provide
evidence of brain infarction due to calcific emboli from
AVs (29 –33), an independent association between AV
calcification and clinical stroke has been demonstrated
only in the presence of hemodynamically significant AV
stenosis (4,13). Several studies (7,9,10) have detailed a
relationship between MAC and clinical stroke, but this
was not confirmed by a prior report from the CHS or by
a separate study using a matched control group (3,8,34).
The weight of the evidence, although varied and seem-
ingly conflicted, favors the presence of some association
between mitral and/or aortic calcification and clinical
ischemic stroke.
To our knowledge, our study is the first to demonstrate
an association between left-sided cardiac annular or valvular
calcifications and covert brain infarcts. Most studies of
calcific AV disease do not detail the presence of concomi-
tant AAC, and it may be that AAC is an underappreciated
exposure in stroke risk. Our results are important because
ongciations Among
odel 2 p Value Model 3 p Value Model 4 p Value
(1.05–1.47) 0.011 1.24 (1.02–1.50) 0.035 1.27 (1.05–1.53) 0.013
(0.99–1.27) 0.081 1.09 (0.93–1.27) 0.303 1.11 (0.97–1.28) 0.140
(0.96–1.24) 0.179 1.09 (0.93–1.27) 0.290 1.08 (0.94–1.24) 0.288
(0.92–1.18) 0.538 1.05 (0.90–1.22) 0.559 1.08 (0.93–1.24) 0.313
(0.99–1.32) 0.075 1.11 (0.93–1.32) 0.240 1.15 (0.98–1.35) 0.096
hite). Model 2: adjusted for age, sex, race, body mass index, physical activity, creatinine, systolic
t), diabetes, and the presence of coronary heart disease or congestive heart failure at closest clinic
phy, and left atrial dimension. Model 4: adjusted for age, race, sex, N-terminal pro-brain natriuretics AmAsso
M
1.24
1.12
1.09
1.04
1.14
e, nonw
r, curren
hypertroular calcification.
2177JACC Vol. 57, No. 21, 2011 Rodriguez et al.
May 24, 2011:2172–80 Cardiac Calcification and Silent Brain Infarctscovert MRI-defined brain infarcts and WMLs are associ-
ated with a higher risk for cognitive decline and future
stroke (14,16,17). The implication of our findings is that the
relationship between left-sided cardiac annular or valvular
calcifications and brain infarcts may have been underesti-
mated in prior studies that considered only clinical ischemic
stroke. This relationship may be stronger and of greater
clinical relevance when both covert and overt brain infarcts
are considered.
Several explanations may account for the independent
association of annular or valvular calcific lesions with covert
MRI-defined brain infarcts. These cardiac lesions may not
be just markers of stroke risk based on their association with
atherosclerotic vascular disease (35,36) but may also play a
causative role. Embolization from left-sided cardiac annular
or valvular calcifications can vary from friable ulcerated
calcium deposits to noncalcific (thrombus) embolization
(32,37–40). Evidence of systemic embolism to cerebral,
coronary, renal, and retinal arteries and the peripheral
circulation has been found on autopsy in one-third of
patients with calcific AV disease (30), with evidence of
organized microthrombi observed in 53% of calcified AVs
(41). Wilson et al. (32) noted calcific AV disease as the most
common cardiac abnormality in patients with central retinal
artery occlusion. A potential mechanistic pathway for mi-
cothrombi formation on left-sided calcified structures could
involve turbulent blood flow at the mitral or aortic position,
followed by fragmentation of red cells and release of
Risk Ratios (95% Confidence Intervals) Describing the Associationand Either Covert Brain Infarcts o High WM Grade (>4)Table 4 Risk Ratios (95% Confidence Intervals) Describing theand Either Covert Brain Infarcts or High WM Grade (>
Variable Unadjusted p Value Model 1 p Value
Any annular or
valve calcification
1.39 (1.19–1.64) 0.001 1.33 (1.13–1.56) 0.001
MAC 1.20 (1.07–1.35) 0.002 1.13 (1.00–1.27) 0.042
AAC 1.22 (1.09–1.38) 0.001 1.15 (1.02–1.29) 0.021
AVSc 1.10 (0.97–1.24) 0.123 1.08 (0.96–1.22) 0.201
Any AV calcification* 1.28 (1.11–1.47) 0.001 1.22 (1.06–1.40) 0.006
*Any AV calcification: combination of AAC or AVSc. Model 1: adjusted for age, sex, race (white, non
pressure, total cholesterol, high-density lipoprotein cholesterol, smoking status (never, former, curr
before brain magnetic resonance imaging. Model 3: adjusted for age, race, sex, left ventricular hy
Risk Ratios (95% Confidence Intervals) Describing the AssociationAVSc, MAC, and AAC and High WM Grad (>4)Table 3 Risk Ratios (95% Confidence Intervals) Describing theAVSc, MAC, and AAC and High WM Grade (>4)
Variable Unadjusted p Value Model 1 p Value
Any annular or
valve calcification
1.8 (1.17–2.77) 0.008 1.59 (1.04–2.45) 0.033
MAC 1.34 (0.99–1.81) 0.055 1.14 (0.85–1.54) 0.390
AAc 1.48 (1.10–2.00) 0.010 1.25 (0.92–1.69) 0.154
AvSc 1.29 (0.95–1.76) 0.099 1.25 (0.92–1.69) 0.153
Any AV calcification* 1.64 (1.13–2.38) 0.009 1.44 (1.00–2.10) 0.053
*Any AV calcification: combination of AAC or AVSc. Model 1: adjusted for age, sex, race (white, non
pressure, total cholesterol, high-density lipoprotein cholesterol, smoking status (never, former, curr
before brain magnetic resonance imaging. Model 3: adjusted for age, race, sex, left ventricular hy
peptide, C-reactive protein, cystatin C, and atrial fibrillation.
Abbreviations as in Table 2.peptide, C-reactive protein, cystatin C, and atrial fibrillation.
Abbreviations as in Table 2.adenosine diphosphate and thromboplastin, with resulting
microthrombus formation and noncalcific embolism
(41,42). The incidence of cerebral thromboembolism from
left-sided cardiac annular or valvular calcifications is likely
underestimated. Patients may remain asymptomatic in some
cases depending on the size of emboli (30), and any
neurologic symptoms may be attributed to other competing
causes, such as low cardiac output, small vessel disease, or
atrial fibrillation. A caveat to this argument is that most
infarcts in the CHS were noncortical, which are typically
not cardioembolic (25), suggesting that embolism may not
be the only explanation for covert infarcts in those with
annular or valvular calcification. The number of cortical
infarcts in these CHS participants was not sufficient to
answer the question of whether or not the risk for covert
infarcts with any annular or valvular calcification differs by
infarct location. In addition, the association between annu-
lar or valvular calcification may be through either known or
unknown shared risk factors that were not considered in
these analyses, such as atherosclerotic disease of the aorta
and cervicocranial vasculature.
Regarding WM disease and annular or valvular calcifica-
tion, the mechanism of association is somewhat unclear.
WM disease is found in those with vascular dementia and
may be the consequence of microvasculopathy, edema,
gliosis, as well as chronic ischemia and small infarcts such as
those caused by embolic calcific disease (43). Although it is
true that both WM disease and annular or valvular calcifi-
ong AVSc, MAC, and AACciations Among AVSc, MAC, and AAC
odel 2 p Value Model 3 p Value Model 4 p Value
(1.11–1.54) 0.001 1.30 (1.07–1.57) 0.007 1.33 (1.11–1.59) 0.002
(0.99–1.25) 0.074 1.08 (0.93–1.25) 0.307 1.10 (0.96–1.25) 0.169
(1.01–1.28) 0.035 1.15 (0.99–1.32) 0.062 1.13 (0.99–1.29) 0.072
(0.94–1.19) 0.326 1.06 (0.92–1.23) 0.394 1.09 (0.95–1.24) 0.212
(1.05–1.39) 0.009 1.19 (1.01–1.40) 0.043 1.21 (1.04–1.41) 0.016
. Model 2: adjusted for age, sex, race, body mass index, physical activity, creatinine, systolic blood
betes, and the presence of coronary heart disease or congestive heart failure at closest clinic visit
hy, and left atrial dimension. Model 4: adjusted for age, race, sex, N-terminal pro-brain natriuretic
ongciations Among
odel 2 p Value Model 3 p Value Model 4 p Value
1.04–2.49) 0.033 1.65 (0.98–2.77) 0.058 1.63 (0.99–2.70) 0.055
(0.86–1.57) 0.334 1.13 (0.79–1.62) 0.510 1.12 (0.80–1.58) 0.502
(0.91–1.68) 0.177 1.29 (0.90–1.85) 0.173 1.23 (0.87–1.74) 0.237
(0.91–1.68) 0.166 1.37 (0.94–1.99) 0.097 1.39 (0.98–1.97) 0.061
(1.00–2.11) 0.050 1.60 (1.01–2.53) 0.045 1.49 (0.97–2.28) 0.068
. Model 2: adjusted for age, sex, race, body mass index, physical activity, creatinine, systolic blood
betes, and the presence of coronary heart disease or congestive heart failure at closest clinic visit
hy, and left atrial dimension. Model 4: adjusted for age, race, sex, N-terminal pro-brain natriuretics AmAsso
4)
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association may be coincidental, the independent association
after adjusting for age and multiple confounders argues against
a coincidence of common risk factors or residual confounding.
Furthermore, the strength of association, as measured by risk
ratios, for WM disease was greater than that for covert brain
infarcts and annular or valvular calcification.
Figure 2 Risk Ratios by Valve Calcification Severity Predicting
*Adjusted for age, sex, race, body mass index, physical activity, creatinine, systol
betes, and the presence of coronary heart disease or congestive heart failure at c
with no mitral valve (MV) or aortic valve (AV) calcification.
Figure 3 Risk Ratios by Valve Calcification Severity Predicting
*Adjusted for age, sex, race, body mass index, physical activity, creatinine, systol
betes, and the presence of coronary heart disease or congestive heart failure at c
with no MV or AV calcification. Abbreviations as in Figure 2.Strengths of our study include its large sample size and
derivation from a well-defined community-based cohort. In
the present study, 2-dimensional visualization of annular or
valvular calcification may have allowed for the more accurate
identification of calcification than was possible with
M-mode examination performed in earlier published stud-
ies. In addition, we were able to adjust our models for
rt Brain Infarcts
d pressure, total cholesterol, high-density lipoprotein cholesterol, smoking, dia-
clinic visit before brain magnetic resonance imaging. Comparison group: those
r Covert Brain Infarcts and/or White Matter Lesions
d pressure, total cholesterol, high-density lipoprotein cholesterol, smoking, dia-
clinic visit prior to brain magnetic resonance imaging. Comparison group: thoseCove
ic bloo
losestEithe
ic bloo
losest
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other important potential confounders.
Our study also had several limitations. First, we per-
formed brain MRI 1 to 2 years before the echocardiographic
examinations. Thus, causality cannot be inferred. In doing
this as a cross-sectional analysis, we are assuming that
changes in measures determined on MRI are slow, so that
those variables remain close to what they would be had they
been obtained at the time of the echocardiographic exami-
nation. Although the issue of reverse causality exists, it is
not biologically plausible that covert brain infarcts would
cause annular or valvular calcification. Moreover, because
such covert infarcts would not lead to immediate disability,
there would be less of a short-term clinical impact of these
lesions than would be observed from clinically apparent
overt stroke. Second, although our statistical models were
extensive, unmeasured confounders could potentially ex-
plain the observed associations. Third, our classification
scheme for left-sided annular or valvular calcification can be
criticized. MAC, AAC, and AVSc are distinct disease
processes but with significant overlap and correlation char-
acterized by common initial pathology of lipid infiltration,
components of chronic inflammation, and calcification (28).
This disease process is manifested and progresses differently,
possibly because of different flow hemodynamic parameters
between the mitral and aortic annuli. We looked at these
cardiac lesions as an aggregate because of the threat of
calcific and thrombotic systemic embolism, which is typi-
cally unique to left-sided lesions unless there is a patent
foramen ovale present. We defined AV calcification as
calcification within the AV leaflets or valve annulus. Thus,
AAC, AVSc, and aortic stenosis represent different points
along the same histopathologic spectrum. Last, the majority
of CHS participants were Caucasian, possibly reducing the
generalizability of our findings to other ethnic groups of
older adults.
Conclusions
Our results indicate that left-sided cardiac annular or
valvular calcification is associated with covert MRI-defined
brain infarcts. Prior estimates of the association between
calcific annular or valve disease and stroke may be underes-
timated, because they accounted only for clinical overt
Covert Brain Infarct Location Accordingto Calcific An ular or Valve Disease StatusTable 5 Covert Brain Infarct Location Accordingto Calcific Annular or Valve Disease Status
Infarct
Location
In Those Without
Any Annular or Valve
Calcification
In Those With Any
Annular or Valve
Calcification
Risk Ratio
(95% Confidence
Interval)*
Noncortical 18% (121/647) 81% (526/647) 1.23 (1.03–1.47)
Cortical 15% (10/65) 85% (55/65) 1.64 (0.84–3.21)
*Adjusted for age, sex, race, body mass index, physical activity, creatinine, systolic blood pressure,
total cholesterol, high-density lipoprotein cholesterol, smoking status (never, former, current),
diabetes, and the presence of coronary heart disease or congestive heart failure at closest clinic
visit before brain magnetic resonance imaging.stroke. Further study is warranted to identify the mecha-nisms relating these 2 sets of findings in the heart and brain
and determine whether intervening in the progression of
calcific annular or valvular disease can reduce the incidence
of these covert MRI findings as well as the associated risk
for cognitive decline and future stroke.
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